Thomas Klein

20.7k citations
499 papers · 17.1k · 2 hit papers · h-index 67

Impact in

Papers in

    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms 51
    • Immune Cell Function and Interaction 34
    • Immune Response and Inflammation 31
    • Cannabis and Cannabinoid Research 61

Thomas Klein

465 papers receiving 16.2k citations

Thomas Klein's Hit Papers

Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors 2011 · 510 citations
5100+7+14Years since publication200400600

Peers

Thomas Klein
Comparison fields: 5 of 195
  • Biological Psychiatry 761
  • Pharmacology 4.9k
  • Endocrinology 1.2k
  • Endocrinology, Diabetes and Metabolism 2.7k
  • Immunology 2.8k
Replace Ana María Cuervo with:
Ana María Cuervo United States
Janet M. Lord United Kingdom
Stefan Schreiber Germany
Vilhelm A. Bohr United States
Jing Liu China
Pietro Ghezzi Italy
Andrea Cossarizza Italy
Ajay Chawla United States
Mark G. Currie United States
Judith Campisi United States
Thomas Klein relative to Ana María Cuervo United States Ana María Cuervo's profile →
Citations per field
00.5×8.6×
Ana María Cuervo · 1×
Citations per year

Countries citing papers authored by Thomas Klein

Since Specialization
Citations

This map shows the geographic impact of Thomas Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Klein more than expected).

Fields of papers citing papers by Thomas Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Klein. The network helps show where Thomas Klein may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Klein Line = papers co-authored together Thomas Klein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 499 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cannabinoid-based drugs as anti-inflammatory therapeutics
Hit paper breakdown →
2005601
2
Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors
Hit paper breakdown →
2011510
3 2003442
4 2009420
5 2005335
6 1997323
7 2003275
8 2006219
9 1998205
10 2001204
11 2000188
12 1995186
13 1998182
14 1988169
15 1994166
16 2012160
17 1998159
18 1989156
19 1997153
20 1994148

About Thomas Klein

Thomas Klein is a scholar working on Immunology, Pharmacology, Molecular Biology, Endocrinology and Endocrinology, Diabetes and Metabolism, having authored 499 papers that have together received 17.1k indexed citations. Recurring topics across this work include Legionella and Acanthamoeba research (79 papers), Cannabis and Cannabinoid Research (61 papers), Diabetes Treatment and Management (57 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (51 papers), Immune Cell Function and Interaction (34 papers), Immune Response and Inflammation (31 papers), Pancreatic function and diabetes (25 papers) and Intergenerational Family Dynamics and Caregiving (23 papers). The work is most often cited by research in Biological Psychiatry (761 citations), Pharmacology (4.9k citations), Endocrinology (1.2k citations), Endocrinology, Diabetes and Metabolism (2.7k citations) and Immunology (2.8k citations). Thomas Klein has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Herman Friedman, Catherine Newton, Yoshimasa Yamamoto, Cathy Newton, Rolf M. Nüsing, Michael Mark, R Widen, C. Newton, Izabella Perkins and Herman Friedman. Their work appears in journals such as Infection and Immunity, Advances in experimental medicine and biology, Experimental Biology and Medicine, Zeitschrift für Soziologie and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact